Ascentage Pharma Group International (AAPG)

AAPG Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Net Income	-360.54	-925.64	-882.92
Depreciation & Amortization	-	93.2	62.92
Share-Based Compensation	-	31.5	22.11
Other Operating Activities	-351.47	74.94	143.99
Operating Cash Flow	-712	-726.08	-653.92
Acquisitions	-	-20	-20
Change in Investments	-	98.75	-130
Other Investing Activities	-5.99	-56.83	-234.61
Investing Cash Flow	-44.58	21.92	-384.61
Dividends Paid	-	-56.84	-236.96
Share Issuance / Repurchase	-	464.17	-26.76
Debt Issued / Paid	-	-13.36	695.87
Other Financing Activities	310.02	-25.21	187.11
Financing Cash Flow	310.02	368.75	619.27
Net Cash Flow	-446.56	-335.4	-419.26
Free Cash Flow	-750.59	-782.92	-890.88
Free Cash Flow Margin	-83.12%	-352.69%	-424.81%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).